Find us on facebook Find us on twitter
Clinical Neurophysiology
Clinical Neurophysiology is the official journal of IFCN and its member Societies. It has been adopted as the official journal of the Italian Society of Clinical Neurophysiology, the Czech Society of Clinical Neurophysiology, the Brazilian Society of Clinical Neurophysiology and the International Society of Intraoperative Neurophysiology.

To secure an individual subscription to Clinical Neurophysiology, please click here.

 
All studies published in Clinical Neurophysiology must stand on their own and make a substantial contribution to the literature.  The journal does not afford a high priority to 'pilot' or 'preliminary' studies or to negative studies that do not advance knowledge.

For author guidelines and other data on the journal or to submit a manuscript, please click here.

Scope of the Journal

  • Clinical Neurophysiology publishes scholarly reports on the pathophysiology underlying diseases of the peripheral and central nervous system of human patients. Clinical trials that use neurophysiological measures to document change or neurophysiological techniques for treatment are encouraged, as are manuscripts reporting data on integrated neuroimaging of peripheral and central nervous function including, but not limited to, functional MRI, brain mapping, MEG, EEG, PET, ultrasound, and other neuroimaging modalities.
    Clinical Neurophysiology covers epilepsy, developmental clinical neurophysiology, psychophysiology and psychopathology, motor control and movement disorders, somatosensory disorders including pain, motor neuron diseases, neuromuscular diseases, neuropathies, sleep and disorders of consciousness, auditory and vestibular disorders, aging, Alzheimer's disease, other dementias, other psychiatric disorders, autonomic disorders, neural plasticity and recovery, and therapeutic clinical neurophysiology including non-invasive and invasive brain stimulation. However the journal is not a methodological journal, and studies reporting normative data collected with routine neurophysiological procedures are of low priority.

  • Reviews of topical areas from recognised experts are normally invited by the Editor-in-Chief, on the recommendations of the Associate Editors and Editorial Board, and are subject to full peer review.

  • The Senior Editors now will consider Case Reports only as Letters. They will however be fully peer-reviewed, as will letters commenting on published papers.

Journal Standing

2016 JCR Impact Factor: 3.866
(Clarivate Analytics, 2017);
Ranking in Clinical Neurology: 43 of 194 (Clarivate Analytics, 2017)
Total Citations in 2016 to items published
in 2014 & 2015: 2,053 (Clarivate Analytics, 2017);
 
 •   Total Citations in 2016: 17,871 (Clarivate Analytics,
2017);
 
   •   Total Citable Items in 2016: 390 (Clarivate Analytics,
2017);
 
Eigenfactor Score 0.02192;  
Immediacy Index 1.100;  
    Average impact factor over the last 5 years: 3.658     

As explained in Wikipedia: "The Eigenfactor approach is thought to be more robust than the impact factor metric, which purely counts incoming citations without considering the significance of those citations. ….. journals are rated according to the number of incoming citations, with citations from highly-ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly-ranked journals."

Editorial Board

Editor-in-Chief: Ulf Ziemann (Tübingen, Germany)

Current Associate Editors:
Robert J. Barry (Wollongong, Australia)
James G. Colebatch (Sydney, Australia)
Zaļ¬ris J. Daskalakis (Toronto, Canada)
Christian Krarup (Copenhagen, Denmark)
Andrea A. Kühn (Berlin, Germany)
Ron Lesser (Baltimore, USA)
David MacDonald (Riyadh, Saudi Arabia)
Hartwig R. Siebner (Copenhagen, Denmark)
John-Stuart Brittain (Oxford, UK)
Andrea Truini (Rome, Italy)
Yoshikazu Ugawa (Fukushima, Japan)

Current Management Board: Members of the Executive Committee, IFCN

Current Editorial Board:
M. Abe (Sendai, Japan)
B. Abou-Khalil (Nashville, USA)
G. Alarcon (London, UK) 
L. Bateman (New York, USA)
O. Bai (Richmond, USA)
M. Ballegaard (Copenhagen, Denmark)
M. Bareš (Brno, Czech Republic)
U. Baumgaertner (Mannheim, Germany)
A. Bendixen (Chemnitz, Germany)
A. Berardelli (Rome, Italy)
J. Bragatti (Porto Alegre, Brazil)
C. Chu (Boston, USA)
V. Deletis (New York, USA)
S. Dimitriadis (Cardiff, UK)
E. Donchin (Tampa, USA)
R. Ferri (Troina Enna, Italy)
S. Finnigan (Brisbane, Australia)
S. Franceschetti (Milan, Italy)
H. Franssen (Utrecht, Netherlands)
A.G. Guggisberg (Geneva,Switzerland)
L. Hobson-Webb (Durham, USA)
C. Hawco (Toronto, Canada)
R. Ishii (Osaka, Japan)
J. Jacobs (Freiburg, Germany)
M. Kinoshita (Kyoto, Japan)
M. Knikou (Staten Island, USA)
M. Kofler (Zirl, Austria)
A.V. Krishnan (Sydney, Australia) 
                    
                                                 
J. Kraus (Prague, Czech Republic)
D.J. Krusienski (Norfolk, USA)
S. Lewis (Sydney, Australia)     
D. Mathersul (Palo Alto, USA)
H. Matsumoto (Tokyo, Japan)
R. Matsumoto (Kyoto, Japan)      
M. Moldovan (Copenhagen, Denmark)            
T. Murakami (Fukushima, Japan)
T. Murofushi (Kawaskai, Japan)
S. Nandedkar (Hopewell Junction, USA)
N. Nakasato (Sendai, Japan)                 
S. Olbrich (Leipzig, Germany)
M. Ozgoren (Izmir, Turkey)
E.S. Papathanasiou (Nicosia, Greece)
T. Rajji (Toronto, Canada)
S. Rampp (Erlangen, Germany)
M. Ridding (Adelaide, Australia)
T. Rosburg (Saarbrücken, Germany)
S. Rosengren (Sydney, Australia)                   
D.L. Schomer (Boston, USA)
Y. Shirota (Tokyo, Japan)
M. Stecker (Mineola, USA)
A. Suppa (Rome, Italy)
A. Szelényi (Munich, Germany)
M. Takemi (Kanagawa, Japan)
O. Vucic (Wentworthville, Australia)